Compare ARQQ & NHS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | ARQQ | NHS |
|---|---|---|
| Founded | 2017 | 2003 |
| Country | United Kingdom | United States |
| Employees | N/A | N/A |
| Industry | Computer Software: Prepackaged Software | Trusts Except Educational Religious and Charitable |
| Sector | Technology | Finance |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 465.3M | 218.5M |
| IPO Year | N/A | N/A |
| Metric | ARQQ | NHS |
|---|---|---|
| Price | $28.41 | $7.33 |
| Analyst Decision | Strong Buy | |
| Analyst Count | 1 | 0 |
| Target Price | ★ $60.00 | N/A |
| AVG Volume (30 Days) | ★ 383.6K | 111.8K |
| Earning Date | 12-09-2025 | 01-01-0001 |
| Dividend Yield | N/A | ★ 13.44% |
| EPS Growth | N/A | N/A |
| EPS | N/A | ★ N/A |
| Revenue | ★ $530,000.00 | N/A |
| Revenue This Year | $183.60 | N/A |
| Revenue Next Year | N/A | N/A |
| P/E Ratio | N/A | N/A |
| Revenue Growth | N/A | ★ N/A |
| 52 Week Low | $11.00 | $6.95 |
| 52 Week High | $62.00 | $9.17 |
| Indicator | ARQQ | NHS |
|---|---|---|
| Relative Strength Index (RSI) | 44.55 | 51.51 |
| Support Level | $27.50 | $7.22 |
| Resistance Level | $31.75 | $7.34 |
| Average True Range (ATR) | 2.26 | 0.06 |
| MACD | 0.68 | 0.02 |
| Stochastic Oscillator | 58.53 | 81.99 |
Arqit Quantum Inc is a cybersecurity company that has pioneered a symmetric key agreement technology that makes the communications links of any networked device or data at rest secure against current and future forms of cyber attack - even an attack from a quantum computer. The company delivers its symmetric key agreement technology via its product SKA-Platform. The firm operates in one segment that is, the provision of cybersecurity services. The company operates and generates its revenue from UK.
Neuberger Berman High Yield Strategies Fund Inc is a diversified, closed-end management investment company. The company invests in high yield debt securities market. The Fund uses leverage to pursue its investment objective. The Fund may invest in a variety of direct debt instruments, including bank loans, notes and other interests in amounts owed to financial institutions by borrowers, such as companies and governments. Corporate loans in which the Fund may invest will consist of direct obligations of borrowers. The Fund may invest in corporate loans at origination as a co-lender or may acquire loans in the secondary market by purchasing participations in, assignments of or novations of corporate loans.